Role of Topical Cyclosporine “A” in Recurrent Adenoviral Keratitis and Dry Eyes
Mona Sune, Pradeep G. Sune, Praveen K. Tidke, Ruchi V. Mishra
Citation Information :
Sune M, Sune PG, Tidke PK, Mishra RV. Role of Topical Cyclosporine “A” in Recurrent Adenoviral Keratitis and Dry Eyes. 2011; 39 (2ENG):2-5.
Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000; 107:1220.
Barber LD, Pflugfelder SC, Tauber J, Foulks GN. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years. Ophthalmology 2005; 112:1790-1794.
Stonecipher K, Perry HD, Gross RH, Kerney DL. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca. Curr Med Res Opin 2005; 21:1057- 1063.
Ho S, Clipstone N, Timmermann L, Northrop J, Graef I, Fiorentino D, Nourse J, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol. 1996 Sep;80(3 Pt 2):S40-5.
Perry HD, Donnenfeld ED, Kanellopoulos AJ, Grossman GA. Topical cyclosporine A in the management of post-keratoplasty glaucoma. Cornea 1997; 16:284-288.
Salib G, McDonald M, Smolek M. Safety and efficacy of cyclosporine 0.05% drops vs. unpreserved artificial tears in dry eye LASIK patients. J Cataract Refract Surg In press.
Akpek EK, Dart JK, Watson S, et al. A randomized trial of topical cyclosporine 0.05% in topical steroid-resistant atopic keratoconjunctivitis. Ophthalmology 2004; 111:476-482.
Perry HD, Doshi-Carnevale S, Donnenfeld ED, Solomon R, Biser SA, Bloom AH. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea In press.
Perry HD, Doshi-Carnevale S, Donnenfeld ED, Kornstein HS. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis. Ophthalmology 2003; 110:1578-1581.
Kanchana Natarajan, Maitreyi S., Rajala, and James Chodosh. Corneal IL-8 Expression Following Adenovirus Infection Is Mediated by c-Src Activation in Human Corneal Fibroblasts. The Journal of Immunology 2003; 170: 6234-6243.
